Immupharma Share Discussion Threads

[kop202] 10/7/2018 11:08

I have.... but I was just hoping deltalo's statement was more than just wishful thinking

[stockriser] 10/7/2018 10:40

KoP - Have you never seen a share on AIM rise with no news?

Edit: Many an RNS has stated after large rises of 100/200/300% - "notes the increase in the Company's share price over the past few weeks, and can confirm it knows of no specific reason for the increase."

[kop202] 10/7/2018 10:24

But why deltalo?Where is the news to back such a move

[deltalo] 10/7/2018 09:15

Moving, we could go above 30p soon.

[nobbygnome] 10/7/2018 07:48

The results are out from che's favourite company TLY.....and they are relatively good! It won't necessarily be quick due to IIs selling but massive rises are to come there IMHO. After all the company is profitable has £10 million cash and despite that is valued at 1/9 turnover (including Vocare turnover for a whole year).

I have never seen a more undervalued company in my investing life.....

Nobby

[kop202] 09/7/2018 13:01

Kirk ....dangerous game....your not related to Corrie's Kirky are you?

[rathean] 09/7/2018 11:03

Still playing the day trade here but for a more solid if illiquid stock take a look at AMYT. imo a medium term hold ahead of trial results, difference is they earn revenue from licenced drug sales so no cap in hand to shareholders every few months.

[nobbygnome] 09/7/2018 10:29

Well I hope a few people got into OPTI 😜....

Ken

Yes I had a few and have been selling them; I was down to £2000 worth (now £1000 LOL) so my smallest holding by far. Something didn't smell right to me. I only bought them on momentum and have made a tidy sum trading them over the last few months!

C'est la vie.

Nobby

[ken chung] 09/7/2018 08:44

Did you also have N4P?

Share price collapsing today on its drug failure.

[glennrcharles] 08/7/2018 22:31

Yes a good OPTIon.

[dontshoutatonce] 08/7/2018 13:17

I second that Nobby, though I have been frustrated by their not having an income for years. Been with them an age but I now think their time is coming.

[nobbygnome] 08/7/2018 11:16

My next tip but DYOR and is just IMHO (for immy 😜) is OPTI. Long term seller has gone, loads of deals have been signed or are on the table with more to come and the momentum is building. I strongly suspect we will see over 80p this week (IMHO) so a good 10% for the short termers on AIM.

Nobby

[kirk 6] 07/7/2018 19:51

1retirement fair point didn't expect these to go back quite so low but have the available cash to keep averaging down! My average is on 23.8 so a spike up will sort me out !

[kirk 6] 06/7/2018 15:38

These will hopefully be rising soon. I haven’t finished here yet, Currently hold 600k and will be buying more next week. Gla

[watchman50] 06/7/2018 14:01

NJB, thanks for you're thoughts, I certainly agree some form of a further phase 3 study will be required, hopefully with a decent sized partner on board. Still wondering why Bryan, Garnier & Co came on board in March and will be interesting to see what part they will/may play moving forward (feel it needs to be a partner tie-up rather than another fund raise IMHO)

In the meantime I can't really see it going much lower over the next six months so will continue to hold and let it play out a while.

[deltalo] 06/7/2018 13:09

Best to hold in here, next rns will see this back up to where it belongs. I'm surprised it hasn't already started in the meantime. I'm staying put here.

[arab3] 06/7/2018 12:14

NY Boy - 05 Jul 2018 - 10:06:52 - 32920 of 32951 IMMUPHARMA - IN FINAL PHASE 3 LUPUS TRIAL TARGETING BLOCKBUSTER ($1bn+) REVENUES - IMM
Better off in (AOR)imho, strong management, great little company , still only 60pâ€482;s but broker sets 400p price target, which should be achievable inside 2 yrs, iâ€͐2;ll drink to that!

like a man u fan changing his colours lol

[njb67] 06/7/2018 08:18

watch

On an NDA, sorry, I do not know. NG would likely be able to answer that one.

Wrt the full results, the best IMM can hope for is an indication that Lupuzor may work in a sub group of patients. They would though need to conduct another phase three study to prove the hypothesis as the analyses in this study would not have been powered (designed with sufficient patients) to prove statistical significance.

[watchman50] 06/7/2018 07:52

NJB, thanks for your thoughts on timings for results news flows - kinda fits in with my own thinking. Guess if there is some good news to come out of the full results analysis they will be keen to get it out there as soon as possible.

In your opinion, will those on the open label follow-on be subject to a NDA? Was hoping I'd come across some anecdotal blogging from somebody on it but nothing yet.

[rakepat37] 06/7/2018 05:57

Even more good news https://dailym.ai/2MQSvZf

[rakepat37] 06/7/2018 05:48

Breaking news ..... all good http://www.smallcapnetwork.com/Blog/s/via/55681/blog/p/mid/1/